Relevant disclosures attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Malar Hospitals Limited's Board approved audited standalone (PAT: Rs 479.12 lakhs) and consolidated (PAT: Rs 472.60 lakhs) results for FY 2025-26. Both figures show substantial growth from Rs 58.59 lakhs and Rs 56.81 lakhs respectively in FY 2024-25. The company now has virtually no business operations after selling its hospital business to MGM Healthcare via slump sale. Total income is only Rs 65.63 lakhs (from other income/interest), with no revenue from operations. Statutory auditors B S R & Co. LLP issued unmodified opinions but included an 'Emphasis of Matter' noting the company has ceased operations with no visibility of new business, and management is evaluating corporate restructuring options. The company updated its Materiality Determination Policy and Insider Trading Code. Key contingent liabilities include medico-legal claims (~Rs 649.40 lakhs), VAT (~Rs 254.93 lakhs), GST (~Rs 22.23 lakhs), and Income Tax (~Rs 198.83 lakhs) matters being contested.
This is a significant red flag for investors. The company has become a shell entity with no operating business after the slump sale, and the auditors' emphasis on going concern despite clean opinions signals material uncertainty about the company's future. The stock may face delisting risks or major restructuring. The PAT growth is misleading since it comes from interest income on sale proceeds, not operations.